Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study

BACKGROUND: The uncertainty about COVID-19 outcomes in angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. This study aimed to determine the effect of ACEI/ARB use in patients with severe COVID-19. METHODS: This retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Alrashed, Ahmed A., Khan, Tahir M., Alhusseini, Noara K., Asdaq, Syed Mohammed Basheeruddin, Enani, Mushira, Alosaimi, Bandar, Alkhani, Nada M., Mohzari, Yahya, Alghalbi, Maram M., Alfahad, Wafa, Alanazi, Mona A., Albujaidya, Asma S., Ben-Akresh, Amal, Almutairi, Malak, Abraham, Ivo, Alamer, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986317/
https://www.ncbi.nlm.nih.gov/pubmed/34020213
http://dx.doi.org/10.1016/j.jiph.2021.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986317/
https://www.ncbi.nlm.nih.gov/pubmed/34020213
http://dx.doi.org/10.1016/j.jiph.2021.03.004

Ejemplares similares